1. Home
  2. KNSA vs PAGS Comparison

KNSA vs PAGS Comparison

Compare KNSA & PAGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • PAGS
  • Stock Information
  • Founded
  • KNSA 2015
  • PAGS 2006
  • Country
  • KNSA United Kingdom
  • PAGS Brazil
  • Employees
  • KNSA N/A
  • PAGS N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • PAGS EDP Services
  • Sector
  • KNSA Health Care
  • PAGS Technology
  • Exchange
  • KNSA Nasdaq
  • PAGS Nasdaq
  • Market Cap
  • KNSA 2.6B
  • PAGS 2.9B
  • IPO Year
  • KNSA 2018
  • PAGS N/A
  • Fundamental
  • Price
  • KNSA $38.51
  • PAGS N/A
  • Analyst Decision
  • KNSA Strong Buy
  • PAGS Strong Buy
  • Analyst Count
  • KNSA 7
  • PAGS 6
  • Target Price
  • KNSA $44.00
  • PAGS $12.33
  • AVG Volume (30 Days)
  • KNSA 392.4K
  • PAGS 4.8M
  • Earning Date
  • KNSA 10-28-2025
  • PAGS 11-12-2025
  • Dividend Yield
  • KNSA N/A
  • PAGS 1.50%
  • EPS Growth
  • KNSA N/A
  • PAGS 20.55
  • EPS
  • KNSA 0.07
  • PAGS 1.30
  • Revenue
  • KNSA $529,332,000.00
  • PAGS $3,543,799,551.00
  • Revenue This Year
  • KNSA $37.21
  • PAGS $18.60
  • Revenue Next Year
  • KNSA $12.07
  • PAGS $6.05
  • P/E Ratio
  • KNSA $582.26
  • PAGS $6.92
  • Revenue Growth
  • KNSA 56.18
  • PAGS 14.53
  • 52 Week Low
  • KNSA $17.82
  • PAGS $6.11
  • 52 Week High
  • KNSA $39.12
  • PAGS $11.16
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 64.65
  • PAGS 39.94
  • Support Level
  • KNSA $37.69
  • PAGS $8.96
  • Resistance Level
  • KNSA $38.83
  • PAGS $10.40
  • Average True Range (ATR)
  • KNSA 0.95
  • PAGS 0.35
  • MACD
  • KNSA 0.00
  • PAGS -0.18
  • Stochastic Oscillator
  • KNSA 79.11
  • PAGS 6.36

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About PAGS PagSeguro Digital Ltd.

PagSeguro Digital Ltd is a Brazilian-based company that acts as a provider of financial technology solutions focused on Micro-Merchants, Small Companies and Medium-Sized Companies (SMEs), in Brazil. The company provides a range of solutions and tools such as cash-in and cash-out options and provides access to working capital to help to manage its cash flow. It delivers an end-to-end digital ecosystem to address day-to-day financial needs, including receiving and spending funds and managing and growing businesses for clients. The company also offers the Free PagSeguro Digital Account delivering Cash-In Solutions, Online and In-Person Payment Tools, Online Payment Tools; and Web Check Outs offer tokenization, handling of shipping information, and others.

Share on Social Networks: